115 related articles for article (PubMed ID: 3783592)
1. Furanose-pyranose isomerization of reduced pyrimidine and cyclic urea ribosides.
Kelley JA; Driscoll JS; McCormack JJ; Roth JS; Marquez VE
J Med Chem; 1986 Nov; 29(11):2351-8. PubMed ID: 3783592
[TBL] [Abstract][Full Text] [Related]
2. Epimer interconversion, isomerization, and hydrolysis of tetrahydrouridine: implications for cytidine deaminase inhibition.
Xiang TX; Niemi R; Bummer P; Anderson BD
J Pharm Sci; 2003 Oct; 92(10):2027-39. PubMed ID: 14502542
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of pyrimidin-2-one nucleosides as acid-stable inhibitors of cytidine deaminase.
Kim CH; Marquez VE; Mao DT; Haines DR; McCormack JJ
J Med Chem; 1986 Aug; 29(8):1374-80. PubMed ID: 3735306
[TBL] [Abstract][Full Text] [Related]
4. On the interaction of 3,4,5,6-tetrahydrouridine with human liver cytidine deaminase.
Wentworth DF; Wolfenden R
Biochemistry; 1975 Nov; 14(23):5099-105. PubMed ID: 53069
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Escherichia coli cytidine deaminase by a phosphapyrimidine nucleoside.
Ashley GW; Bartlett PA
J Biol Chem; 1984 Nov; 259(21):13621-7. PubMed ID: 6386818
[TBL] [Abstract][Full Text] [Related]
6. Influence of tetrahydrouridine on the pharmacokinetics of intrathecally administered 1-beta-D-arabinofuranosylcytosine.
Riccardi R; Chabner B; Glaubiger DL; Wood J; Poplack DG
Cancer Res; 1982 May; 42(5):1736-9. PubMed ID: 6896013
[TBL] [Abstract][Full Text] [Related]
7. Potent inhibitors for the deamination of cytosine arabinoside and 5-aza-2'-deoxycytidine by human cytidine deaminase.
Laliberté J; Marquez VE; Momparler RL
Cancer Chemother Pharmacol; 1992; 30(1):7-11. PubMed ID: 1375134
[TBL] [Abstract][Full Text] [Related]
8. Phase I evaluation of tetrahydrouridine combined with cytosine arabinoside.
Wong PP; Currie VE; Mackey RW; Krakoff IH; Tan CT; Burchenal JH; Young CW
Cancer Treat Rep; 1979 Aug; 63(8):1245-9. PubMed ID: 383291
[TBL] [Abstract][Full Text] [Related]
9. Tetrahydrouridine: Physiologic disposition and effect upon deamination of cytosine arabinoside in man.
Kreis W; Woodcock TM; Gordon CS; Krakoff IH
Cancer Treat Rep; 1977 Oct; 61(7):1347-53. PubMed ID: 589600
[TBL] [Abstract][Full Text] [Related]
10. Combinations of tetrahydrouridine and cytosine arabinoside in mouse tumors.
Kreis W; Hession C; Soricelli A; Scully K
Cancer Treat Rep; 1977 Oct; 61(7):1355-64. PubMed ID: 589601
[TBL] [Abstract][Full Text] [Related]
11. Pharmacology of combination chemotherapy of cytosine arabinoside (ara-C) and uracil arabinoside (ara-U) or tetrahydrouridine (THU) against murine leukemia L1210/0 in tumor-bearing mice.
Avramis VI; Powell W
Cancer Invest; 1987; 5(4):293-9. PubMed ID: 3664332
[TBL] [Abstract][Full Text] [Related]
12. Effect of tetrahydrouridine on metabolism and transport of 1-beta-D-arabinofuranosylcytosine in human cells.
Riva C; Barra Y; Carcassonne Y; Cano JP; Rustum Y
Chemotherapy; 1992; 38(5):358-66. PubMed ID: 1286578
[TBL] [Abstract][Full Text] [Related]
13. Isomerization of 5-Hydroxy-5-methylhydantoin 2'-Deoxynucleoside into α-Furanose, β-Furanose, α-Pyranose, and β-Pyranose Anomers.
Ali A; Wagner JR
Chem Res Toxicol; 2016 Jan; 29(1):65-74. PubMed ID: 26616794
[TBL] [Abstract][Full Text] [Related]
14. Cyclic urea nucleosides. Cytidine deaminase activity as a function of aglycon ring size.
Liu PS; Marquez VE; Driscoll JS; Fuller RW; McCormack JJ
J Med Chem; 1981 Jun; 24(6):662-6. PubMed ID: 7252974
[TBL] [Abstract][Full Text] [Related]
15. Analysis of cytidine deaminase and tetrahydrouridine interaction by use of ligand techniques.
Stoller RG; Myers CE; Chabner BA
Biochem Pharmacol; 1978 Jan; 27(1):53-9. PubMed ID: 619907
[No Abstract] [Full Text] [Related]
16. Deoxycytidine transport in the presence of a cytidine deaminase inhibitor and the transport of uracil in Escherichia coli B.
von Dippe PJ; Leung K; Roy-Burman S; Visser DW
J Biol Chem; 1975 May; 250(10):3666-71. PubMed ID: 1092677
[TBL] [Abstract][Full Text] [Related]
17. Effect of tetrahydrouridine on the action of 1-beta-D-arabinofuranosylcytosine in synchronized cultures of normal rat kidney cells.
Wan CW; Mak TW
Cancer Res; 1979 Oct; 39(10):3981-5. PubMed ID: 476637
[TBL] [Abstract][Full Text] [Related]
18. A phosphorus-containing pyrimidine analog as a potent inhibitor of cytidine deaminase.
Ashley GW; Bartlett PA
Biochem Biophys Res Commun; 1982 Oct; 108(4):1467-74. PubMed ID: 6758781
[No Abstract] [Full Text] [Related]
19. Quantitative determination of the cytidine deaminase inhibitor tetrahydrouridine (THU) in mouse plasma by liquid chromatography/electrospray ionization tandem mass spectrometry.
Parise RA; Egorin MJ; Eiseman JL; Joseph E; Covey JM; Beumer JH
Rapid Commun Mass Spectrom; 2007; 21(13):1991-7. PubMed ID: 17526067
[TBL] [Abstract][Full Text] [Related]
20. Plasma pharmacokinetics and oral bioavailability of 3,4,5,6-tetrahydrouridine, a cytidine deaminase inhibitor, in mice.
Beumer JH; Eiseman JL; Parise RA; Florian JA; Joseph E; D'Argenio DZ; Parker RS; Kay B; Covey JM; Egorin MJ
Cancer Chemother Pharmacol; 2008 Aug; 62(3):457-64. PubMed ID: 18008070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
